APA (7th ed.) Citation

S, I., S, E., L, E., A, S., E, B., M, P., . . . D, L. (2019). Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy. Current hematologic malignancy reports, 14(1), 47. https://doi.org/10.1007/s11899-019-0498-6

Chicago Style (17th ed.) Citation

S, Ittershagen, et al. "Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy." Current Hematologic Malignancy Reports 14, no. 1 (2019): 47. https://doi.org/10.1007/s11899-019-0498-6.

MLA (9th ed.) Citation

S, Ittershagen, et al. "Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy." Current Hematologic Malignancy Reports, vol. 14, no. 1, 2019, p. 47, https://doi.org/10.1007/s11899-019-0498-6.